EIKN Company Profile and Key Details

NASDAQ : EIKN

Eikon Therapeutics Common Stock

$13.18

-0.84-5.99%

At Close 4:00 PM

Profile Key Stats Analyst Ratings Ownership Ratios Financials Dividend & splits Sentiment Forecast

Price Chart

Stock Price Today

Eikon Therapeutics, Inc. Common Stock (EIKN) stock declined over -5.99%, trading at $13.18 on NASDAQ, down from the previous close of $14.02. The stock opened at $14.20, fluctuating between $12.63 and $14.60 in the recent session.

Stock Snapshot

14.02

Prev. Close

38.89M

Market Cap

12.63

Day Low

-2.23

P/E Ratio

-5.91

EPS (TTM)

N/A

Cash Flow per Share

14.2

Open

2.95M

Number of Shares

14.5961

Day High

N/A

Free Float in %

N/A

Book Value

394.62K

Volume

Relevant Articles

SEC Fillings

Current Report (8-k)

Filing Date	Accepted Date

Annual Report (10-k)

Filing Date	Accepted Date

Stock Price History Chart

Date	Open	High	Low	Close	Volume
Mar 11, 2026	14.20	14.60	12.62	13.18	394.62K
Mar 10, 2026	14.99	15.17	14.02	14.02	168.51K
Mar 09, 2026	14.16	15.78	14.10	14.91	273.13K
Mar 06, 2026	14.58	14.77	13.84	14.38	202.57K
Mar 03, 2026	14.88	15.36	13.62	13.80	144.19K
Mar 02, 2026	14.18	14.95	13.61	14.88	420.44K
Feb 27, 2026	13.49	14.28	13.49	13.78	270.8K
Feb 26, 2026	14.47	14.94	13.39	13.64	432.48K
Feb 25, 2026	14.94	15.43	14.51	14.89	191.51K
Feb 24, 2026	14.23	15.23	14.21	14.90	336.04K
Feb 23, 2026	15.23	15.23	13.51	14.47	305.04K
Feb 20, 2026	15.89	15.89	14.73	14.88	267.64K
Feb 19, 2026	16.50	16.50	14.50	15.50	809.29K
Feb 18, 2026	15.75	16.39	15.53	16.26	443.39K
Feb 17, 2026	15.35	16.25	15.25	15.72	481.91K
Feb 13, 2026	14.82	16.16	14.50	15.05	307.2K
Feb 12, 2026	14.57	15.77	14.39	14.83	368.87K
Feb 11, 2026	13.60	14.68	13.28	14.49	312.62K
Feb 10, 2026	14.56	14.99	13.30	13.59	419.91K
Feb 09, 2026	15.87	15.87	14.11	14.55	438.45K

Contact Details

Millbrae, CA 94030

United States

https://eikontx.com 341 777 0566

About Company

Eikon Therapeutics, Inc., operates as a clinical biopharmaceutical company in the United States. It develops innovative medicines to address serious unmet medical needs. It develops a platform that permits precise characterization of protein interactions in living cells. Its products includes EIK1001 is a systemically administered TLR 7/8 dual-agonist designed to activate innate and adaptive immune anti-tumor responses; EIK1003 and EIK1004 are selective PARP1 inhibitors in ovarian, breast, prostate, and pancreatic cancers and, specifically with the brain-penetrant; EIK1004, to address brain metastases and primary brain malignancies; EIK1005 a potent WRN helicase inhibitor and anti-tumor agent for MSI-high tumors; and EIK1006. The company was incorporated in 2019 and is based in Millbrae, California.

Stock Peers

REGN

2.63+0.34%

Regeneron Pharmaceuticals, Inc.$774.66 ARGX

-14.7-1.98%

argenx SE$728.09 UTHR

8.9+1.66%

United Therapeutics Corporation$544.71 VRTX

-6.79-1.36%

Vertex Pharmaceuticals Incorporated$492.38 MDGL

-1.25-0.29%

Madrigal Pharmaceuticals, Inc.$431.53 KRTX

0.09+0.03%

Karuna Therapeutics, Inc.$329.83 ALNY

-1.95-0.60%

Alnylam Pharmaceuticals, Inc.$320.43 PRAX

-12.94-4.18%

Praxis Precision Medicines, Inc.$296.97 KRYS

-6.08-2.33%

Krystal Biotech, Inc.$255.00 SGEN

-0.16-0.07%

Seagen Inc.$228.74

Company Overview

Eikon Therapeutics, Inc. Common Stock (NASDAQ:EIKN) closed at $13.18 USD, losing -$0.84 (-5.99%) from the previous close of $14.02. The stock is currently within 5% of its 52-week low $12.63 and $17.40. With a market capitalization of about $38.89 million, Eikon Therapeutics, Inc. Common Stock is classified as a micro-cap and shows lower-than-market volatility (beta ~0.00). Key stats such as the average daily volume over the past year has been around 567.25 thousand shares, volume is running light vs its 52-week average. Headquartered in Millbrae, CA, Eikon Therapeutics, Inc. Common Stock operates in the Healthcare sector and the Biotechnology industry. Eikon Therapeutics, Inc., operates as a clinical biopharmaceutical company in the United States.

Technical Performance

Short-term trend indicators are mixed aligned (SMA20 -7.95%, SMA50 -7.95%, SMA200 -7.95%). The stock’s 14-day RSI is 41.12 (neutral), while the ATR of 1.61 points to higher daily volatility. The stock remains sitting in the mid-range of its 52-week band, trading -21.61% below its high and over 2.67% above its low. Average 10-day trading volume of 267.24 thousand shares is below the 3-month average of 349.43 thousand, indicating normal recent market interest.

Dividend & Fair Value

Dividend and splits history remains an important factor for investors monitoring long-term returns.

Earnings & Analyst Outlook

Analyst sentiment is bullish. Analyst rating data shows there are 3 Strong Buy ratings, 1 Buy ratings, 0 Hold ratings, 0 Sell rating and 1 Strong Sell ratings. Price targets range from $34.00 to $7.00. The high target offers 157.97% upside. The low target suggests -46.89% downside. The mean target is $25.60. This offers 94.23% upside.

Price Forecast & Outlook

Our AI price prediction model suggests that Eikon Therapeutics, Inc. Common Stock stock has strong potential for upside but may face short-term weakness followed by gains in the medium and long term. 2-Week Outlook: Projected increase of 3.19%, with price expected at $13.60 by March 25, 2026, within a range of $12.79 to $14.45 3-Month Outlook: Projected fall of -96.28%, reaching $0.49 by June 08, 2026, with a range of $0.00 to $2.38. 1-Year Outlook: Projected loss of -100.0%, with price at $0.00 by March 11, 2027, within a range of $0.00 to $0.11.

Key Takeaways

currently trading near 52-week highs band. Analyst sentiment is bullish, with the majority of ratings in Overweight territory and a mean price target of $25.60, suggesting 94.23% upside. Our AI forecast model points to short-term strength (3.19% over two weeks), a medium-term fall (-96.28% over three months), and a longer-term loss (-100.0% over one year), with expected trading ranges indicating moderate volatility.

Frequently Asked Questions

What is the current Eikon Therapeutics, Inc. Common Stock (EIKN) stock price?

Eikon Therapeutics, Inc. Common Stock (NASDAQ: EIKN) stock price is $13.18 in the last trading session. During the trading session, EIKN stock reached the peak price of $14.60 while $12.63 was the lowest point it dropped to. The percentage change in EIKN stock occurred in the recent session was -5.99% while the dollar amount for the price change in EIKN stock was - $0.84.

EIKN's industry and sector of operation?

The NASDAQ listed EIKN is part of Biotechnology industry that operates in the broader Healthcare sector. Eikon Therapeutics, Inc. Common Stock designs, manufactures, and markets smartphones, personal computers, tablets, wearables, and accessories worldwide.

Who are the executives of EIKN?

No Data

How EIKN did perform over past 52-week?

EIKN's closing price is 4.36% higher than its 52-week low of $12.63 where as its distance from 52-week high of $17.40 is -24.25%.

How many employees does EIKN have?

Number of EIKN employees currently stands at 0.

Link for EIKN official website?

Official Website of EIKN is: https://eikontx.com

How do I contact EIKN?

EIKN could be contacted at phone 341 777 0566 and can also be accessed through its website. EIKN operates from 230 Harriet Tubman Way, Millbrae, CA 94030, United States.

How many shares of EIKN are traded daily?

EIKN stock volume for the day was 394.62K shares. The average number of EIKN shares traded daily for last 3 months was 567.25K.

What is the market cap of EIKN currently?

The market value of EIKN currently stands at $38.89M with its latest stock price at $13.18 and 2.95M of its shares outstanding.

Stocks Telegraph provides information and tools designed to assist investors and Wall Street players. A major goal is to offer financiers comprehensive information that will help them gain insight into investing.

Stocks Telegraph does not provide any advice or recommendations for buying or selling stocks, securities, or other financial products. Information contained on this website is for informational purposes only and should not be construed as professional financial, investment or other advice. Stocks Telegraph is not liable for any loss or damage that may occur as a result of reliance on this data.

Employees	0
Beta	0
Sales or Revenue	N/A
5Y Sales Change%	N/A
Fiscal Year Ends	N/A
Sector	Healthcare
Industry	Biotechnology

EIKN Company Profile and Key Details

Eikon Therapeutics Common Stock

Price Chart

Stock Price Today

Stock Snapshot

Relevant Articles

SEC Fillings

Current Report (8-k)

Annual Report (10-k)

Stock Price History Chart

Contact Details

About Company

Company Information

Stock Peers

Company Overview

Technical Performance

Dividend & Fair Value

Earnings & Analyst Outlook

Price Forecast & Outlook

Key Takeaways

Frequently Asked Questions

Technical Performance

Earnings & Analyst Outlook

Price Forecast & Outlook

Dividend & Fair Value

Key Takeaways

Company Overview